PTGS2 and neurodegenerative disease: Although the increased expression of Cox-2 in ALS patients and SOD1 mutant mice has been reported [33], one more interesting discovery is that the expression of Cox-2 is specifically increased in ALS patients rather than other neurodegenerative disease cases [34].